Amino acid substitutions in the Candida albicans sterol 5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence
Open Access
- 7 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (9), 2131-2138
- https://doi.org/10.1093/jac/dks186
Abstract
To determine the mechanisms responsible for fluconazole resistance in two Candida albicans isolates (CAAL2 and CAAL76) recovered from two hospitalized patients after fluconazole prophylaxis. MICs of fluconazole and voriconazole were determined by the broth microdilution method (CLSI M27-A3), and by Etest® for amphotericin B. RNA expression levels of CDR1, MDR1 and ERG11 were determined by RT–PCR. Mutations in ERG11 and ERG3 were investigated by amplification and sequencing. Sterol membrane profiles were determined by gas chromatography–mass spectrometry (GC–MS). In vivo virulence was determined in a murine model of invasive candidiasis. Both isolates displayed azole cross-resistance and reduced susceptibility to amphotericin B, and are novel Δ5,6-desaturase (Erg3p) mutants. CAAL2 harbours a new amino acid substitution (L193R), whereas a 13 bp deletion leading to a truncated Erg3p (Δ366–378) was found in CAAL76. Both genetic alterations impaired Erg3p function as shown by GC–MS in these isolates (ergosterol content below 10%, and accumulation of ergosta-7,22-dienol above 40%). In vivo, in a murine model of invasive candidiasis, both CAAL2 and CAAL76 exhibited a significant trend toward reduced virulence, which seems to be linked to a reduced capacity for hyphal growth. These findings demonstrate the critical role of residue 193 in Erg3p function and azole resistance. We suggest that this attenuated in vivo virulence phenotype could be linked to lower potential for hyphal growth. Taken together, our findings highlight the fact that erg3 mutants must be considered in future studies aiming at investigating azole antifungal drug resistance.This publication has 30 references indexed in Scilit:
- Rare and emerging Candida speciesCurrent Fungal Infection Reports, 2009
- Triazole-resistant candidaemia following posaconazole exposureInternational Journal of Antimicrobial Agents, 2009
- Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strainsMolecular Microbiology, 2008
- A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans IsolateEukaryotic Cell, 2008
- Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans IsolatesEukaryotic Cell, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasisInternational Journal of Antimicrobial Agents, 2006
- A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicansGenetics, 2006
- Inactivation of Sterol Δ 5,6 -Desaturase Attenuates Virulence in Candida albicansAntimicrobial Agents and Chemotherapy, 2005
- Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to AzolesAntimicrobial Agents and Chemotherapy, 2004